RhumbLine Advisers’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.7M Buy
247,736
+27,608
+13% +$1.19M 0.01% 1028
2025
Q1
$7.61M Buy
220,128
+1,008
+0.5% +$34.8K 0.01% 1141
2024
Q4
$6.01M Buy
219,120
+5,007
+2% +$137K 0.01% 1333
2024
Q3
$5.45M Sell
214,113
-7,290
-3% -$186K ﹤0.01% 1387
2024
Q2
$5.61M Buy
221,403
+36,199
+20% +$917K 0.01% 1333
2024
Q1
$5.73M Buy
185,204
+4,374
+2% +$135K 0.01% 1345
2023
Q4
$7.3M Buy
180,830
+1,071
+0.6% +$43.2K 0.01% 1213
2023
Q3
$4.74M Buy
179,759
+1,924
+1% +$50.7K 0.01% 1379
2023
Q2
$3.06M Buy
177,835
+15,448
+10% +$266K ﹤0.01% 1669
2023
Q1
$2.69M Buy
162,387
+4,448
+3% +$73.7K ﹤0.01% 1656
2022
Q4
$1.2M Buy
157,939
+5,635
+4% +$42.9K ﹤0.01% 2037
2022
Q3
$1.51M Buy
152,304
+11,293
+8% +$112K ﹤0.01% 1924
2022
Q2
$1.28M Buy
141,011
+17,520
+14% +$159K ﹤0.01% 2019
2022
Q1
$1.25M Sell
123,491
-3,841
-3% -$39K ﹤0.01% 2038
2021
Q4
$2.12M Sell
127,332
-899
-0.7% -$15K ﹤0.01% 1845
2021
Q3
$6.01M Buy
128,231
+1,755
+1% +$82.3K 0.01% 1248
2021
Q2
$7.71M Buy
126,476
+22,957
+22% +$1.4M 0.01% 1168
2021
Q1
$6.38M Buy
103,519
+11,525
+13% +$710K 0.01% 1267
2020
Q4
$6.54M Buy
91,994
+577
+0.6% +$41K 0.01% 1197
2020
Q3
$3.43M Sell
91,417
-21,815
-19% -$819K 0.01% 1387
2020
Q2
$3.69M Buy
113,232
+7,986
+8% +$260K 0.01% 1382
2020
Q1
$3.05M Buy
105,246
+77,018
+273% +$2.23M 0.01% 1314
2019
Q4
$989K Buy
28,228
+3,696
+15% +$129K ﹤0.01% 2091
2019
Q3
$527K Buy
+24,532
New +$527K ﹤0.01% 2297